G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Executive Director, Oncology Integrated Insights & Analytics - Global Oncology Integrated Insights

Business AnalysisConfirmed live in the last 24 hours
Full-timeFoster City, CA, USA

About the Job

Requirements

  • A Bachelor's degree and 14 years of experience, or a Master's degree and 12 years of experience, or a PhD and 12 years of experience.
  • Understand commercial analytics, market research methodologies, and forecasting, as well as Data Science and its application to commercial questions.
  • Frame complex or ambiguous business questions and translate evidence into recommendations that shape strategy and action.
  • Lead major cross-functional initiatives and influence senior stakeholders laterally and vertically, including without direct authority.
  • Understand pharmaceutical commercialization, product lifecycle management, and the regulatory environment.
  • Communicate effectively with executives, simplify complexity, facilitate productive debate, resolve conflict, and build alignment among diverse stakeholders.
  • Have experience across multiple stages of the Oncology lifecycle, from pipeline and portfolio choices through launch, growth, and lifecycle strategy.
  • Integrate multiple analytical disciplines into a single strategic perspective.
  • Apply strategic judgment and constructively challenge conventional wisdom while grounding recommendations in evidence.
  • Create organizational capability, not simply manage established processes.
  • Build talent by attracting strong people, developing future leaders, and creating an inclusive culture characterized by curiosity, accountability, and high standards.
  • Optimize for the broader business and patient opportunity rather than the interests of an individual analytical discipline.

Responsibilities

  • Serve as a senior strategic and analytical thought partner to Oncology leaders, helping define the questions and choices with the greatest implications for the portfolio and business.
  • Bring together market research, analytics, forecasting, and other relevant evidence to develop an integrated perspective.
  • Translate complex evidence into clear strategic implications, choices, and recommendations that senior leaders can act upon.
  • Shape decisions spanning disease-area strategy, pipeline and portfolio assessment, launch strategy, positioning, lifecycle opportunities, business development assessments, and long-range strategic planning.
  • Connect Oncology primary and secondary research and analytical efforts so leaders understand what is happening, why it matters, what may happen next, and what the organization should do.
  • Build partnerships across global Oncology teams and enterprise functions, aligning stakeholders around high-priority business questions and evidence needs.
  • Challenge assumptions in senior discussions and help teams distinguish signal from noise in complex or ambiguous situations.
  • Influence across organizational boundaries and levels, including where the role lacks formal decision authority.
  • Engage Portfolio Analytics, Supply Chain, Medical, and Data Science partners to frame business questions and combine expertise around major strategic choices.
  • Strengthen connectivity with affiliate and country analytics teams so insight and learning move across the global organization.
  • Support enterprise processes, including the Oncology earnings narrative and long-range strategic planning.
  • Lead, develop, and inspire a multidisciplinary team across Market Research, Analytics, and Forecasting.
  • Create an inclusive environment where differing perspectives are sought and healthy debate improves decisions.
  • Develop talent by understanding employees' strengths, aspirations, and potential, and providing coaching, feedback, and growth opportunities.
  • Empower teams with clear purpose and accountability, remove barriers, and connect their work to the broader organization.
  • Attract and develop people who combine analytical excellence with curiosity, business judgment, collaboration, and the courage to challenge established thinking.
  • Foster a culture of learning and measurement, using appropriate KPIs and feedback loops to improve decisions and performance.
  • Evolve how Market Research, Analytics, and Forecasting work together to increase the speed, quality, and strategic value of insights.
  • Partner with Data Science and Data Management leadership, using advanced techniques to support Oncology market shaping and launches.
  • Champion thoughtful use of AI, advanced analytics, automation, and new approaches to insight synthesis where they improve decision support.
  • Enable responsible experimentation, rapid learning, and scaling of approaches that demonstrate business value.
  • Maintain analytical rigor while encouraging the organization to challenge legacy approaches and adopt better methods when supported by evidence.
  • Create inclusion by modeling inclusive management and embedding the value of diversity in team management.
  • Develop talent by coaching employees on current performance and future potential and ensuring they receive feedback and insight to grow.
  • Empower teams by aligning goals and purpose with organizational objectives, holding teams accountable, removing barriers, and connecting them to the broader ecosystem.

Desired Qualifications

  • Experience applying advanced analytics, AI, or automation to improve how insights are generated, synthesized, or used in decision-making.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs